Clinical Trial Detail

NCT ID NCT01307956
Title Panitumumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Advanced Esophageal or Gastroesophageal Junction Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma


Fluorouracil + Leucovorin + Oxaliplatin + Panitumumab

Age Groups: adult

No variant requirements are available.